We characterized US pediatric patients with clinical indicators of genetic diseases, focusing
on the burden of disease, utilization of genetic testing, and cost of care. Curated lists of …

Background Genetic testing in nephrology is increasingly described in the literature and
several groups have suggested significant clinical benefit. However, studies to date have …

Background: Due to racial, cultural, and linguistic marginalization, some populations
experience disproportionate barriers to genetic testing in both clinical and research settings …

When genetic tests are not funded publicly, out‐of‐pocket (OOP) pay options may be
discussed with patients. We evaluated trends in genetic testing and OOP pay for two publicly …

Advances in genetic technologies have made genetic testing more accessible than ever
before. However, depending on national, regional, legal, and health insurance …

The Multidisciplinary Ophthalmic Genetics Clinic (MOGC) at the University of Michigan
Kellogg Eye Center aims to provide medical and ophthalmic genetics care to patients with …

Purpose Little is known about how Medicaid coverage policies affect access to genetic tests
for pediatric patients. Building upon and extending a previous analysis of prior authorization …

Purpose Genomic medicine can end diagnostic odysseys for patients with complex
phenotypes; however, limitations in insurance coverage and other systemic barriers …

Diagnostic genome sequencing (GS) in newborns may have many benefits. More accurate
diagnosis could spur the development of innovative genomic therapies. A precise diagnosis …

In rapidly progressing cancers, appropriate selection of first-line therapy is essential in
prolonging survival. Alongside immunohistochemistry (IHC), comprehensive genomics …